Logo-bi
Review
Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(1): 7-22. doi: 10.5681/bi.2011.003
PMCID: PMC3648943     PMID: 23678403     Scopus ID: 84876715577     Viewed: 15255
PDFPDF
XMLXML
Cited By:
Graphical Abstract
Original Research COVID-19
Khalil Ansarin ORCID, Ramin Tolouian, Mohammadreza Ardalan* ORCID, Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri ORCID, Kenneth R. Chapman ORCID
Bioimpacts. 2020;10(4): 209-215. doi: 10.34172/bi.2020.27
PMCID: PMC7502909     PMID: 32983936     Scopus ID: 85092050012     Viewed: 11741
Graphical Abstract
Based on a randomized clinical trial, bromhexine is proposed as a potential therapeutic option in COVID-19. A total of 78 patients with similar demographic and disease characteristics were treated with results showing a significant reduction in ICU admissions.
Original Research
Bryson C. Lochte, Sean A Guillory, Craig A. H. Richard*, William M. Kelley
Bioimpacts. 2018;8(4): 295-304. doi: 10.15171/bi.2018.32
PMCID: PMC6209833     PMID: 30397584     Scopus ID: 85056080325     Viewed: 11021
Graphical Abstract
Review
Srinivasan Shanmugam*
Bioimpacts. 2015;5(1): 55-63. doi: 10.15171/bi.2015.04
PMCID: PMC4401168     PMID: 25901297     Scopus ID: 84924905436     Viewed: 7346
Graphical Abstract
Short Communication
Morteza Mahmoudi, Mingming Zhao, Yuka Matsuura, Sophie Laurent, Phillip C. Yang, Daniel Bernstein, Pilar Ruiz-Lozano*, Vahid Serpooshan*
Bioimpacts. 2016;6(2): 111-115. doi: 10.15171/bi.2016.16
PMCID: PMC4981249     PMID: 27525229     Scopus ID: 84983548259     Viewed: 4206
Graphical Abstract
Original Research
Yalda RahbarSaadat, Nazli Saeidi, Sepideh Zununi Vahed, Abolfazl Barzegari*, Jaleh Barar ORCID
Bioimpacts. 2015;5(1): 25-28. doi: 10.15171/bi.2015.01
PMCID: PMC4401164     PMID: 25901294     Scopus ID: 84924904679     Viewed: 4105
Graphical Abstract
Research Education
Farhad Shokraneh, Roghayeh Ilghami, Rasoul Masoomi, Alireza Amanollahi*
Bioimpacts. 2012;2(1): 61-68. doi: 10.5681/bi.2012.008
PMCID: PMC3648921     PMID: 23678443     Scopus ID: 84876787047     Viewed: 4062
PDFPDF
XMLXML
Cited By:
Review
Ali Nokhodchi*, Shaista Raja, Pryia Patel, Kofi Asare-Addo
Bioimpacts. 2012;2(4): 175-187. doi: 10.5681/bi.2012.027
PMCID: PMC3648939     PMID: 23678458     Scopus ID: 84876799240     Viewed: 4056
Graphical Abstract
Methodology
Farhad Shokraneh* ORCID, Clive Elliott Adams ORCID
Bioimpacts. 2017;7(4): 209-217. doi: 10.15171/bi.2017.25
PMCID: PMC5801532     PMID: 29435428     Scopus ID: 85040670486     Viewed: 4050
Graphical Abstract
Review
Jaleh Barar ORCID, Mohammad A. Rafi, Mohammad M. Pourseif, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(4): 225-248. doi: 10.15171/bi.2016.30
PMCID: PMC5326671     PMID: 28265539     Scopus ID: 85013096202     Viewed: 3836
Graphical Abstract

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences and provides free editing services. 
Acceptance rate: 24%
First decision: 2-3 days  
Final decision:
3-6 weeks 
Publication fee: Free of charge